| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 41 | 2021 | 596 | 6.100 |
Why?
|
| Cardiac Surgical Procedures | 38 | 2021 | 450 | 4.880 |
Why?
|
| Hypoplastic Left Heart Syndrome | 17 | 2016 | 138 | 2.370 |
Why?
|
| Pulmonary Artery | 15 | 2014 | 323 | 2.250 |
Why?
|
| Heart Ventricles | 14 | 2017 | 738 | 1.810 |
Why?
|
| Cardiopulmonary Bypass | 14 | 2019 | 250 | 1.780 |
Why?
|
| Fontan Procedure | 12 | 2015 | 129 | 1.670 |
Why?
|
| Infant, Newborn | 49 | 2021 | 2455 | 1.660 |
Why?
|
| Heart Valve Prosthesis | 9 | 2018 | 222 | 1.650 |
Why?
|
| Transposition of Great Vessels | 5 | 2022 | 51 | 1.640 |
Why?
|
| Palliative Care | 13 | 2017 | 271 | 1.580 |
Why?
|
| Postoperative Complications | 25 | 2022 | 1615 | 1.320 |
Why?
|
| Heart Transplantation | 9 | 2019 | 328 | 1.230 |
Why?
|
| Norwood Procedures | 7 | 2016 | 61 | 1.220 |
Why?
|
| Heart Bypass, Right | 6 | 2017 | 30 | 1.190 |
Why?
|
| Aorta, Thoracic | 5 | 2018 | 211 | 1.170 |
Why?
|
| Infant | 45 | 2022 | 2891 | 1.160 |
Why?
|
| Heart Valve Prosthesis Implantation | 7 | 2018 | 164 | 1.140 |
Why?
|
| Bioprosthesis | 3 | 2017 | 101 | 1.070 |
Why?
|
| Oxygen | 10 | 2014 | 386 | 1.050 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2013 | 59 | 0.990 |
Why?
|
| Humans | 113 | 2022 | 68618 | 0.980 |
Why?
|
| Vena Cava, Superior | 3 | 2014 | 41 | 0.930 |
Why?
|
| Hemodynamics | 13 | 2018 | 705 | 0.920 |
Why?
|
| Vocal Cord Paralysis | 2 | 2018 | 18 | 0.870 |
Why?
|
| Treatment Outcome | 42 | 2022 | 7029 | 0.850 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2015 | 189 | 0.820 |
Why?
|
| Pulmonary Valve | 2 | 2017 | 40 | 0.780 |
Why?
|
| Preoperative Care | 8 | 2017 | 275 | 0.740 |
Why?
|
| Child, Preschool | 24 | 2018 | 3187 | 0.740 |
Why?
|
| Education, Medical, Continuing | 2 | 2011 | 136 | 0.720 |
Why?
|
| Cardiology | 2 | 2011 | 140 | 0.710 |
Why?
|
| Thoracic Surgery | 4 | 2015 | 72 | 0.700 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2017 | 36 | 0.660 |
Why?
|
| Decision Support Techniques | 4 | 2016 | 191 | 0.650 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2022 | 47 | 0.650 |
Why?
|
| Child | 27 | 2019 | 6405 | 0.640 |
Why?
|
| Brain Injuries | 2 | 2021 | 268 | 0.640 |
Why?
|
| Heart Diseases | 3 | 2018 | 276 | 0.640 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 16 | 0.640 |
Why?
|
| Aneurysm, False | 3 | 2014 | 60 | 0.630 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2015 | 37 | 0.630 |
Why?
|
| Aortic Diseases | 2 | 2022 | 113 | 0.620 |
Why?
|
| Blood Coagulation | 2 | 2017 | 123 | 0.600 |
Why?
|
| Larynx | 1 | 2018 | 49 | 0.600 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2017 | 24 | 0.590 |
Why?
|
| Pulmonary Circulation | 3 | 2014 | 79 | 0.570 |
Why?
|
| Oxygen Consumption | 4 | 2008 | 258 | 0.560 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 88 | 0.560 |
Why?
|
| Waiting Lists | 1 | 2017 | 104 | 0.540 |
Why?
|
| Male | 62 | 2021 | 37321 | 0.540 |
Why?
|
| Periodicals as Topic | 2 | 2015 | 158 | 0.540 |
Why?
|
| Aortic Coarctation | 3 | 2014 | 37 | 0.520 |
Why?
|
| Reoperation | 10 | 2018 | 467 | 0.520 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2015 | 9 | 0.510 |
Why?
|
| White Matter | 1 | 2018 | 174 | 0.510 |
Why?
|
| Hydrocortisone | 1 | 2016 | 291 | 0.500 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2015 | 45 | 0.490 |
Why?
|
| Surgical Procedures, Operative | 1 | 2015 | 124 | 0.490 |
Why?
|
| Thrombosis | 5 | 2015 | 218 | 0.480 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2014 | 11 | 0.470 |
Why?
|
| Female | 55 | 2021 | 38074 | 0.470 |
Why?
|
| Adolescent | 22 | 2018 | 8912 | 0.450 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 21 | 0.450 |
Why?
|
| Fluid Therapy | 1 | 2014 | 59 | 0.450 |
Why?
|
| Plasma | 2 | 2004 | 58 | 0.450 |
Why?
|
| Stents | 3 | 2016 | 657 | 0.440 |
Why?
|
| Cerebrovascular Circulation | 5 | 2015 | 296 | 0.440 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2012 | 123 | 0.430 |
Why?
|
| Methylprednisolone | 5 | 2021 | 99 | 0.430 |
Why?
|
| Prosthesis Implantation | 1 | 2013 | 83 | 0.420 |
Why?
|
| Device Removal | 1 | 2013 | 100 | 0.420 |
Why?
|
| Coronary Vessels | 1 | 2015 | 313 | 0.420 |
Why?
|
| Aortic Valve | 6 | 2018 | 249 | 0.420 |
Why?
|
| Aprotinin | 3 | 2011 | 55 | 0.400 |
Why?
|
| Infant, Premature | 5 | 2017 | 284 | 0.400 |
Why?
|
| Hyperventilation | 2 | 2004 | 6 | 0.400 |
Why?
|
| Follow-Up Studies | 17 | 2022 | 3259 | 0.380 |
Why?
|
| Time Factors | 14 | 2021 | 4655 | 0.380 |
Why?
|
| Brachiocephalic Trunk | 2 | 2009 | 11 | 0.370 |
Why?
|
| Multivariate Analysis | 7 | 2016 | 1046 | 0.370 |
Why?
|
| Risk Factors | 14 | 2018 | 5731 | 0.360 |
Why?
|
| Hospital Mortality | 6 | 2016 | 384 | 0.360 |
Why?
|
| Echocardiography | 7 | 2017 | 515 | 0.360 |
Why?
|
| Pleural Effusion | 2 | 2012 | 74 | 0.360 |
Why?
|
| Risk Assessment | 10 | 2017 | 2007 | 0.360 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2009 | 36 | 0.340 |
Why?
|
| Tetralogy of Fallot | 2 | 2007 | 43 | 0.340 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 38 | 0.330 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2021 | 50 | 0.330 |
Why?
|
| Heart Valve Diseases | 3 | 2010 | 123 | 0.330 |
Why?
|
| Program Development | 2 | 2009 | 240 | 0.330 |
Why?
|
| Retrospective Studies | 22 | 2022 | 7277 | 0.330 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2017 | 38 | 0.330 |
Why?
|
| Heart Atria | 2 | 2006 | 206 | 0.320 |
Why?
|
| Deglutition Disorders | 2 | 2017 | 297 | 0.310 |
Why?
|
| Blood Gas Analysis | 2 | 2005 | 41 | 0.310 |
Why?
|
| Glucocorticoids | 4 | 2019 | 222 | 0.310 |
Why?
|
| Anticoagulants | 3 | 2006 | 356 | 0.300 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2010 | 48 | 0.300 |
Why?
|
| Models, Cardiovascular | 3 | 2017 | 133 | 0.290 |
Why?
|
| Cardiac Catheterization | 8 | 2016 | 419 | 0.290 |
Why?
|
| Anastomosis, Surgical | 7 | 2013 | 104 | 0.290 |
Why?
|
| Coronary Thrombosis | 1 | 2006 | 45 | 0.280 |
Why?
|
| Abnormalities, Multiple | 2 | 2012 | 109 | 0.280 |
Why?
|
| Postoperative Care | 3 | 2011 | 163 | 0.270 |
Why?
|
| Prospective Studies | 14 | 2021 | 3705 | 0.270 |
Why?
|
| Recovery of Function | 2 | 2021 | 506 | 0.270 |
Why?
|
| Warfarin | 3 | 2006 | 93 | 0.260 |
Why?
|
| Cytokines | 5 | 2013 | 866 | 0.250 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2006 | 117 | 0.250 |
Why?
|
| Carbon Dioxide | 2 | 2003 | 78 | 0.250 |
Why?
|
| Young Adult | 7 | 2018 | 5717 | 0.250 |
Why?
|
| Prevalence | 4 | 2018 | 1619 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 772 | 0.240 |
Why?
|
| Matrix Metalloproteinases | 3 | 2010 | 223 | 0.240 |
Why?
|
| History, 20th Century | 2 | 2015 | 248 | 0.240 |
Why?
|
| Length of Stay | 8 | 2016 | 780 | 0.240 |
Why?
|
| Thromboembolism | 2 | 2002 | 91 | 0.240 |
Why?
|
| United States | 9 | 2019 | 7367 | 0.230 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 2279 | 0.230 |
Why?
|
| Myocardial Contraction | 2 | 2017 | 383 | 0.220 |
Why?
|
| Protein C Deficiency | 1 | 2003 | 5 | 0.220 |
Why?
|
| Graft Rejection | 2 | 2017 | 458 | 0.220 |
Why?
|
| Regional Blood Flow | 3 | 2014 | 168 | 0.220 |
Why?
|
| Factor V | 1 | 2002 | 20 | 0.210 |
Why?
|
| Subclavian Artery | 2 | 2014 | 30 | 0.210 |
Why?
|
| Prosthesis Design | 5 | 2017 | 301 | 0.210 |
Why?
|
| Hemostatics | 1 | 2003 | 47 | 0.210 |
Why?
|
| Infant, Low Birth Weight | 2 | 2021 | 84 | 0.210 |
Why?
|
| Mitral Valve | 4 | 2018 | 166 | 0.210 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2013 | 99 | 0.210 |
Why?
|
| Lung | 2 | 2009 | 849 | 0.210 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2002 | 69 | 0.200 |
Why?
|
| Proportional Hazards Models | 5 | 2018 | 792 | 0.200 |
Why?
|
| Aortopulmonary Septal Defect | 1 | 2002 | 2 | 0.200 |
Why?
|
| Arterial Switch Operation | 1 | 2022 | 10 | 0.200 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 110 | 0.200 |
Why?
|
| Return to Work | 1 | 2021 | 6 | 0.200 |
Why?
|
| Collateral Circulation | 1 | 2002 | 34 | 0.200 |
Why?
|
| Sternotomy | 2 | 2013 | 18 | 0.200 |
Why?
|
| Vasoconstrictor Agents | 2 | 2017 | 107 | 0.200 |
Why?
|
| Incidence | 5 | 2019 | 1603 | 0.200 |
Why?
|
| Survival Analysis | 7 | 2018 | 714 | 0.200 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 1465 | 0.190 |
Why?
|
| South Carolina | 6 | 2014 | 2752 | 0.190 |
Why?
|
| Odds Ratio | 5 | 2016 | 880 | 0.190 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2014 | 186 | 0.190 |
Why?
|
| Discrete Subaortic Stenosis | 1 | 2000 | 3 | 0.190 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 244 | 0.190 |
Why?
|
| Disabled Persons | 1 | 2021 | 94 | 0.180 |
Why?
|
| Tranexamic Acid | 2 | 2011 | 37 | 0.180 |
Why?
|
| Child Development | 2 | 2019 | 102 | 0.180 |
Why?
|
| Birth Weight | 1 | 2021 | 186 | 0.180 |
Why?
|
| Antifibrinolytic Agents | 2 | 2011 | 52 | 0.180 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2006 | 373 | 0.180 |
Why?
|
| Survival Rate | 6 | 2007 | 1056 | 0.180 |
Why?
|
| Critical Illness | 1 | 2021 | 191 | 0.180 |
Why?
|
| Aortic Aneurysm | 2 | 2014 | 77 | 0.180 |
Why?
|
| Embolization, Therapeutic | 1 | 2002 | 150 | 0.170 |
Why?
|
| Ventricular Function, Left | 2 | 2017 | 481 | 0.170 |
Why?
|
| Myocardium | 3 | 2015 | 1204 | 0.160 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 92 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 536 | 0.160 |
Why?
|
| Intraoperative Period | 2 | 2019 | 62 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2015 | 2800 | 0.150 |
Why?
|
| Dipyridamole | 1 | 1997 | 26 | 0.150 |
Why?
|
| Mutation | 1 | 2002 | 1213 | 0.150 |
Why?
|
| Adult | 12 | 2018 | 21403 | 0.140 |
Why?
|
| Induction Chemotherapy | 1 | 2017 | 39 | 0.140 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2016 | 106 | 0.140 |
Why?
|
| Prosthesis Failure | 3 | 2013 | 130 | 0.140 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2017 | 37 | 0.140 |
Why?
|
| Ductus Arteriosus | 1 | 2016 | 13 | 0.140 |
Why?
|
| Angiography | 3 | 2016 | 194 | 0.140 |
Why?
|
| Anniversaries and Special Events | 1 | 2015 | 12 | 0.130 |
Why?
|
| Aspirin | 1 | 1997 | 295 | 0.130 |
Why?
|
| Brachiocephalic Veins | 1 | 2015 | 9 | 0.130 |
Why?
|
| Patient Selection | 3 | 2016 | 592 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2017 | 157 | 0.130 |
Why?
|
| Perfusion | 1 | 2015 | 131 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2016 | 100 | 0.120 |
Why?
|
| Cardiac Output, Low | 2 | 2012 | 52 | 0.120 |
Why?
|
| Tissue and Organ Procurement | 1 | 2017 | 164 | 0.120 |
Why?
|
| Blood Pressure | 4 | 2005 | 1451 | 0.120 |
Why?
|
| Body Weight | 1 | 2017 | 554 | 0.120 |
Why?
|
| Hemorrhage | 1 | 2017 | 328 | 0.120 |
Why?
|
| Aneurysm, Infected | 1 | 2014 | 16 | 0.120 |
Why?
|
| Monitoring, Intraoperative | 2 | 2007 | 53 | 0.120 |
Why?
|
| Streptococcal Infections | 1 | 2014 | 53 | 0.120 |
Why?
|
| Graft Survival | 1 | 2017 | 465 | 0.120 |
Why?
|
| Endoscopy | 1 | 2018 | 464 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 186 | 0.120 |
Why?
|
| Heart Septal Defects | 2 | 2012 | 27 | 0.120 |
Why?
|
| Tricuspid Atresia | 2 | 2004 | 4 | 0.120 |
Why?
|
| Arteriovenous Fistula | 1 | 2014 | 25 | 0.120 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 56 | 0.110 |
Why?
|
| Postoperative Period | 4 | 2015 | 238 | 0.110 |
Why?
|
| Middle Aged | 12 | 2021 | 21147 | 0.110 |
Why?
|
| Chest Tubes | 2 | 2012 | 18 | 0.110 |
Why?
|
| Mortality | 2 | 2021 | 163 | 0.110 |
Why?
|
| Histocompatibility | 1 | 2013 | 17 | 0.110 |
Why?
|
| Arteriovenous Malformations | 1 | 2013 | 34 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 514 | 0.110 |
Why?
|
| Aorta | 2 | 2006 | 316 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 136 | 0.110 |
Why?
|
| Endpoint Determination | 1 | 2013 | 82 | 0.110 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2012 | 17 | 0.110 |
Why?
|
| Prognosis | 5 | 2021 | 2093 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2013 | 174 | 0.100 |
Why?
|
| Heart Failure | 3 | 2013 | 1180 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 2324 | 0.100 |
Why?
|
| Alprostadil | 1 | 2012 | 20 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 121 | 0.100 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2012 | 20 | 0.100 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 112 | 0.100 |
Why?
|
| Research Design | 2 | 2013 | 729 | 0.100 |
Why?
|
| Respiration, Artificial | 4 | 2013 | 190 | 0.100 |
Why?
|
| Age Factors | 4 | 2019 | 1864 | 0.100 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2012 | 182 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 371 | 0.100 |
Why?
|
| Postoperative Hemorrhage | 1 | 2011 | 69 | 0.100 |
Why?
|
| Mind-Body Therapies | 1 | 2011 | 4 | 0.100 |
Why?
|
| Holistic Health | 1 | 2011 | 10 | 0.100 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 79 | 0.100 |
Why?
|
| Parents | 1 | 2014 | 312 | 0.090 |
Why?
|
| Biomarkers | 4 | 2021 | 1593 | 0.090 |
Why?
|
| Heart-Assist Devices | 1 | 2013 | 221 | 0.090 |
Why?
|
| Miniaturization | 1 | 2010 | 21 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2013 | 384 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 85 | 0.090 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2009 | 1 | 0.090 |
Why?
|
| Oxazolidinones | 1 | 2009 | 6 | 0.090 |
Why?
|
| Physical Fitness | 1 | 2011 | 117 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 106 | 0.090 |
Why?
|
| Sternum | 1 | 2009 | 19 | 0.090 |
Why?
|
| Pulmonary Ventilation | 1 | 2010 | 28 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2010 | 100 | 0.090 |
Why?
|
| Competency-Based Education | 1 | 2009 | 32 | 0.090 |
Why?
|
| Anticholesteremic Agents | 1 | 2009 | 49 | 0.080 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2009 | 73 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 234 | 0.080 |
Why?
|
| Drainage | 1 | 2010 | 133 | 0.080 |
Why?
|
| Aortography | 2 | 2014 | 72 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2011 | 183 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 2077 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 2 | 2013 | 168 | 0.080 |
Why?
|
| Actuarial Analysis | 3 | 2003 | 23 | 0.080 |
Why?
|
| Quality of Life | 2 | 2014 | 1515 | 0.080 |
Why?
|
| Vitamin D | 1 | 2012 | 516 | 0.080 |
Why?
|
| Respiratory Paralysis | 1 | 2007 | 10 | 0.080 |
Why?
|
| Probability | 2 | 2010 | 245 | 0.080 |
Why?
|
| Drug Administration Schedule | 3 | 2017 | 567 | 0.080 |
Why?
|
| Premedication | 1 | 2007 | 49 | 0.070 |
Why?
|
| Propranolol | 1 | 2007 | 103 | 0.070 |
Why?
|
| Veins | 1 | 2007 | 68 | 0.070 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2013 | 113 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 493 | 0.070 |
Why?
|
| Infant Welfare | 2 | 2004 | 18 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2009 | 239 | 0.070 |
Why?
|
| Aged | 9 | 2021 | 14862 | 0.070 |
Why?
|
| Inflammation | 1 | 2013 | 1030 | 0.070 |
Why?
|
| Double-Blind Method | 3 | 2019 | 1738 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4848 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 189 | 0.070 |
Why?
|
| Blood Flow Velocity | 3 | 2007 | 172 | 0.070 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 546 | 0.070 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2006 | 16 | 0.070 |
Why?
|
| Aneurysm | 1 | 2006 | 53 | 0.070 |
Why?
|
| Embolism | 1 | 2006 | 45 | 0.070 |
Why?
|
| Neurofibromatosis 1 | 1 | 2006 | 39 | 0.070 |
Why?
|
| Ligation | 2 | 2017 | 83 | 0.070 |
Why?
|
| Transplantation | 1 | 2006 | 23 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2009 | 706 | 0.070 |
Why?
|
| Heart Block | 1 | 2005 | 49 | 0.070 |
Why?
|
| Pharyngeal Diseases | 1 | 2005 | 21 | 0.060 |
Why?
|
| Laryngeal Diseases | 1 | 2005 | 22 | 0.060 |
Why?
|
| Vascular Resistance | 2 | 2005 | 179 | 0.060 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2005 | 25 | 0.060 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2006 | 72 | 0.060 |
Why?
|
| Defibrillators, Implantable | 1 | 2009 | 329 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2006 | 113 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2006 | 291 | 0.060 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2005 | 7 | 0.060 |
Why?
|
| Decompression, Surgical | 1 | 2005 | 55 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2007 | 277 | 0.060 |
Why?
|
| Vasopressins | 1 | 2005 | 33 | 0.060 |
Why?
|
| Disasters | 1 | 2007 | 204 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2011 | 824 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2005 | 82 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2004 | 17 | 0.060 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 4 | 0.060 |
Why?
|
| Factor VIII | 1 | 2004 | 27 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2004 | 18 | 0.060 |
Why?
|
| Tidal Volume | 1 | 2004 | 17 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2005 | 141 | 0.060 |
Why?
|
| Trisomy | 1 | 2004 | 47 | 0.060 |
Why?
|
| Platelet Count | 1 | 2004 | 100 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2004 | 242 | 0.060 |
Why?
|
| Thrombectomy | 1 | 2006 | 238 | 0.060 |
Why?
|
| Partial Pressure | 1 | 2003 | 19 | 0.060 |
Why?
|
| Hypoventilation | 1 | 2003 | 8 | 0.060 |
Why?
|
| Fibrinogen | 1 | 2004 | 87 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2003 | 10 | 0.060 |
Why?
|
| Heart Function Tests | 1 | 2003 | 33 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2007 | 448 | 0.060 |
Why?
|
| Gestational Age | 2 | 2017 | 389 | 0.060 |
Why?
|
| Fetal Diseases | 1 | 2004 | 64 | 0.060 |
Why?
|
| Nitroprusside | 1 | 2003 | 42 | 0.060 |
Why?
|
| Bacteremia | 1 | 2005 | 155 | 0.060 |
Why?
|
| Prothrombin Time | 1 | 2003 | 24 | 0.060 |
Why?
|
| Fibroma | 1 | 2003 | 20 | 0.050 |
Why?
|
| Blood Coagulation Disorders, Inherited | 1 | 2002 | 5 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2003 | 33 | 0.050 |
Why?
|
| Tachycardia | 1 | 2003 | 53 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2017 | 622 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2002 | 59 | 0.050 |
Why?
|
| Bradycardia | 1 | 2003 | 45 | 0.050 |
Why?
|
| Logistic Models | 2 | 2017 | 1420 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1745 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2005 | 232 | 0.050 |
Why?
|
| Heparin | 1 | 2003 | 205 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 931 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2002 | 102 | 0.050 |
Why?
|
| Cardiac Output | 2 | 2013 | 133 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2001 | 187 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 807 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2001 | 260 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 2358 | 0.050 |
Why?
|
| Australia | 1 | 2021 | 235 | 0.050 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2013 | 33 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 306 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 696 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 618 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1753 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2003 | 498 | 0.040 |
Why?
|
| Child Language | 1 | 2019 | 5 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2019 | 215 | 0.040 |
Why?
|
| Infant Behavior | 1 | 2019 | 12 | 0.040 |
Why?
|
| Health Status | 1 | 2021 | 429 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2013 | 344 | 0.040 |
Why?
|
| Arteries | 1 | 1998 | 108 | 0.040 |
Why?
|
| Propensity Score | 1 | 2017 | 117 | 0.040 |
Why?
|
| Laryngoscopy | 1 | 2017 | 61 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 682 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 109 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2017 | 152 | 0.030 |
Why?
|
| Motor Activity | 1 | 2019 | 621 | 0.030 |
Why?
|
| Streptococcus mitis | 1 | 2014 | 2 | 0.030 |
Why?
|
| Hospitals, University | 2 | 2006 | 169 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 513 | 0.030 |
Why?
|
| Deglutition | 1 | 2017 | 221 | 0.030 |
Why?
|
| Survival | 1 | 2014 | 22 | 0.030 |
Why?
|
| North America | 1 | 2014 | 112 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 652 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2014 | 120 | 0.030 |
Why?
|
| Disease Management | 2 | 2006 | 248 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 540 | 0.030 |
Why?
|
| Heart Rate | 2 | 2007 | 568 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 213 | 0.030 |
Why?
|
| Suture Techniques | 1 | 2012 | 75 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2013 | 117 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 848 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2012 | 87 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 517 | 0.030 |
Why?
|
| Factor VIIa | 1 | 2011 | 25 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 2011 | 21 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 672 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2011 | 60 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 101 | 0.020 |
Why?
|
| Social Class | 1 | 2012 | 127 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 521 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 72 | 0.020 |
Why?
|
| Standard of Care | 1 | 2011 | 22 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2011 | 133 | 0.020 |
Why?
|
| Animals | 3 | 2014 | 20881 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2011 | 219 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2011 | 91 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 947 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2014 | 413 | 0.020 |
Why?
|
| Glucuronides | 1 | 2009 | 5 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2009 | 41 | 0.020 |
Why?
|
| Bile | 1 | 2009 | 35 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2009 | 41 | 0.020 |
Why?
|
| Urine | 1 | 2009 | 47 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2011 | 218 | 0.020 |
Why?
|
| Biotransformation | 1 | 2009 | 69 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 292 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2009 | 77 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 242 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2009 | 43 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 238 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 742 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2011 | 330 | 0.020 |
Why?
|
| Feces | 1 | 2009 | 88 | 0.020 |
Why?
|
| Heart Valves | 1 | 2011 | 171 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2009 | 55 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 137 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 139 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1140 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 303 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 626 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2009 | 98 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 500 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2009 | 85 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 397 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 346 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2011 | 249 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 333 | 0.020 |
Why?
|
| Phrenic Nerve | 1 | 2007 | 4 | 0.020 |
Why?
|
| Splanchnic Circulation | 1 | 2007 | 11 | 0.020 |
Why?
|
| Hepatic Veins | 1 | 2007 | 13 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 1026 | 0.020 |
Why?
|
| Diaphragm | 1 | 2007 | 22 | 0.020 |
Why?
|
| Portal Vein | 1 | 2007 | 46 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2007 | 71 | 0.020 |
Why?
|
| Vena Cava, Inferior | 1 | 2007 | 41 | 0.020 |
Why?
|
| Indonesia | 1 | 2007 | 11 | 0.020 |
Why?
|
| Small-Area Analysis | 1 | 2007 | 11 | 0.020 |
Why?
|
| Hospitals | 1 | 2009 | 265 | 0.020 |
Why?
|
| Cafe-au-Lait Spots | 1 | 2006 | 1 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 586 | 0.020 |
Why?
|
| Systole | 1 | 2007 | 149 | 0.020 |
Why?
|
| Diastole | 1 | 2007 | 161 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 274 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2007 | 82 | 0.020 |
Why?
|
| Age Distribution | 1 | 2007 | 320 | 0.020 |
Why?
|
| Comprehensive Health Care | 1 | 2006 | 26 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1196 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2550 | 0.020 |
Why?
|
| Enterobacter cloacae | 1 | 2005 | 4 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 420 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 349 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2005 | 164 | 0.020 |
Why?
|
| Myocarditis | 1 | 2005 | 49 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2007 | 601 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 2083 | 0.020 |
Why?
|
| Vascular Patency | 1 | 2005 | 122 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2009 | 657 | 0.020 |
Why?
|
| Europe | 1 | 2004 | 196 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2004 | 73 | 0.010 |
Why?
|
| Canada | 1 | 2004 | 267 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 157 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2003 | 34 | 0.010 |
Why?
|
| Sinoatrial Node | 1 | 2003 | 14 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 334 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 5300 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 1851 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 733 | 0.010 |
Why?
|
| Cause of Death | 1 | 1999 | 241 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 2334 | 0.010 |
Why?
|